Jade Biosciences, Inc. (JBIO) — Financial Flexibility Index
Jade Biosciences, Inc. (JBIO) has a Financial Flexibility Index of -1.05x as of March 2026. Free cash flow of $-24.08 Million (operating CF $-24.08 Million minus capex $0.00) represents -1% of total liabilities ($22.97 Million). Also explore net asset growth rate of Jade Biosciences, Inc. to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Jade Biosciences, Inc. Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for Jade Biosciences, Inc. across 6 annual periods. Check JBIO asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Jade Biosciences, Inc. (2020–2025)
Year-by-year free cash flow to debt coverage for Jade Biosciences, Inc.. For the full company profile including market capitalisation, see Jade Biosciences, Inc. (JBIO) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -5.47x | $-94.49 Million | $-94.69 Million | $17.26 Million | ▲ +70.0% |
| 2024 | -18.26x | $-71.20 Million | $-71.20 Million | $3.90 Million | ▼ -479.3% |
| 2023 | -3.15x | $-56.64 Million | $-56.78 Million | $17.96 Million | ▲ +30.7% |
| 2022 | -4.55x | $-38.93 Million | $-39.12 Million | $8.56 Million | ▲ +50.8% |
| 2021 | -9.24x | $-27.22 Million | $-27.40 Million | $2.94 Million | ▼ -108.6% |
| 2020 | -4.43x | $-7.86 Million | $-7.86 Million | $1.77 Million | — |